• Tidak ada hasil yang ditemukan

Pharmacy bulletin - HCTM

N/A
N/A
Protected

Academic year: 2024

Membagikan "Pharmacy bulletin - HCTM"

Copied!
2
0
0

Teks penuh

(1)

Pharmacy bulletin

PPUKM

EDITION 17 ISSUE 3 2015

RESULTS OF JKTU 2/2015 MEETING

No Drugs Indication & Dose PPUKM Policy

1 CINACALCET 25MG TABLET

(REGPARA®)

Indication: Secondary hyperparathyroidism in pa- tients undergoing maintenance dialysis.

Dose:

One tab Once daily. Dose can be increased by 25mg at a time, at 3 week intervals.

Max: 100mg once daily.

Prescriber: A*: Nephrologist Only Max usage: RM100,000 a year.

*Inj Paricalcitol (Zemplar) is taken out from PPUKM formulary.

Use until stocks last.

2 OXYCODONE/ NA- LOXONE TABLET 5/2.5MG, 10/5MG, 20/10MG, 40/20MG

(TARGIN®)

Indication: Management of moderate to severe chronic pain unresponsive to non-narcotic analgesics, with prevention of opioid-induced constipation.

Dose:

Opioid naïve patients or patients with moderate to severe chronic pain uncontrolled by weaker opioid: Targin tablet 10/5mg at 12 hourly inter- vals.

Mild hepatic & renal impairment: Targin tablet 5/2.5mg at 12 hourly.

Prescriber: A*: Palliative Care Specialist Only

Maximum usage : RM170,000/year Share budget with Oxycodone Immediate Release and Prolonged Release Tablet.

3 ARTESUNATE 60MG INJECTION (IM/IV)

(DUNATE®)

Indication: Severe malaria as detailed by WHO-criteria Dose: 2.4mg/kg at 0, 12, 24, 48 hours once daily.

Day 1: Dose 1 (0 hour); Dose 2 (12 hours) Day 2: Dose 3 (24 hours after first dose) Day 3: Dose 4

Prescriber : A*: Infectious Disease Specialist Only

* Quinine injection drugs 600m taken out from the formulary.

Use until stocks last . The Drug & Therapeutics Committee 2/2015 meeting was recently held on the 10th

of April 2015. Results of the meeting will be implemented starting

1st June 2015

for both new drugs and add-on indication/prescriber.

In view of the recent drug budget cut up to 26% (RM24 million); ALL new drugs appli- cation into the formulary should fulfill ONE of these CRITERIAS :

a) The cost of new drug submitted is cheaper by at least 30% of existing drug for the same indication. (Total cost per year must be considered as well and not just the cost of the drug only).

b) Must suggest to remove an existing drug for the same indication from the formulary.

c) No additional budget allocation required.

Effective from April 2015, all drug application must be made via online at

http://e-jktu.ppukm.ukm.my/. The website which was launched on 1st of March 2015 can be accessed from PPUKM’s official website (refer picture).

(2)

Pharmacy bulletin

No Drugs Indication & Dose PPUKM Policy

1 ADALIMUMAB 40MG INJECTION (HUMIRA®)

Indication: Crohn’s Disease/Ulcerative Colitis Dose:

Week 0: 160mg (Administered as four injections in one day or as two injections per day for two consecutive days)

Week 2: 80mg

Every other week: 40mg (maintenance dose)

Prescriber: A*: Gastroenterologist Only Approved only for 1 patient through patient compassionate program 3+1 FOC.

(Number of patients for both injection Infliximab and Adalimumab is limited to 5 patients)

APPEAL DRUG

No Drugs Indication & Dose PPUKM Policy

1 ETORICOXIB 60MG, 90MG, 120MG

(ARCOXIA®)

Additional STRENGTH in the formulary :

60mg: Osteoarthiritis

90mg: Rheumatoid Arthritis & ankylosing spondilosis

Additional PRESCRIBER :

Palliative Care Specialist and Rheumatologist outpatient and inpatient.

120mg: Acute gouty arthritis, acute pain

& primary dysmenorrhea

Prescriber: A*: Palliative Care Specialist, Rheumatologist & Orthopaedic Surgeons Only

2 RIVASTIGMINE TRANSDERMAL PATCH 13.3MG/24 HOURS

(EXELON 15 PATCH®)

Indication: Mild to moderately severe demen- tia associated with Alzheimer's or Parkinson's disease.

Dose: Start with Exelon Patch 5 once daily, may be increased to Exelon Patch 10 after a minimum of 4 week.

Prescriber: A*: Neurologist & Psychiatrist Only

Use the existing allocation: RM250,000/

year.

Newly Added Indication/Strength/Prescriber

A publication of :

DRUG INFORMATION CENTRE Pharmacy Department, UKM Medical Centre

Izyan Diyana Binti Ibrahim [email protected]

Ext 5415

Michelle Tan Hwee Pheng [email protected]

Ext 5401

http://www.ppukm.ukm.my/farmasi/

We would like to wish all our Muslim colleagues a happy & blessed fasting month of Ramadhan.

May the holy month brings you more prosperity, faith, satisfaction and divine love for Allah.

Referensi

Dokumen terkait

Edition 18, Issue 4 SHORTAGE OF POTASSIUM DIHYDROGEN PHOSPHATE 10 MMOL/10ML INJ P harmacy Bulletin Pharmacy Department, HCTM, PPUKM DRUGS POTASSIUM DIHYDROGEN PHOSPHATE

PPUKM Formulary App is now available on: A publication of Drug Information Centre Article by Nur Hafiza Saripin [email protected] Co-Editors Izyan Diyana Ibrahim

3 ASHP Guidelines on Handling Hazardous Drugs 2004 PPUKM EDITION 16 ISSUE 4 2015 Safe Handling of Hazardous Drugs by Michelle Tan NIOSH ASHP Definitions Carcinogenicity in

Drug Category Specific Drugs For Choice Immunosuppressants / Rheumatic immune drugs Everolimus Adalimumab Infliximab Mycophenolic Acid Corticosteroids Anti-infective Drugs

Indication Alternatives Dose recommendation Anxiety Alprazolam Adult: Oral 0.25-0.5mg TDS usual range 0.5-4mg/day in divided dose *1+ Lorazepam Adult: Oral 1-4mg/day in 2 or 3

Worldwide Discontinuation of Homatropine Eye Dro p Article contribution by PRP Leanne & Lok Ying A publication of Drug Information Centre, Pharmacy Department, HCTM, PPUKM

Drug Categories in PPUKM Drug Category F Formulary SF Special Formulary NF Non Formulary NFS Non-Formulary Policies Drugs and Therapeutics Committee A* drugs :

According to PPUKM extemporaneous worksheet, the syrup can be prepared by crushing 5 tablets of sildenafil 50mg, which is the equivalent of 250mg, and add Extemp syrup up to 100ml of